doi: 10.2139/ssrn.4653984 132 SanzABSanchez-NinoMDRamosAMOrtizA
But in 2003, Congress passed a rule that But if the FDA approves a weight loss drug for another medically accepted use, it can be covered by Medicare prescription drug plans
Study SnapshotStudy TypeSystematic review and meta-analysis, PROSPERO-registered, exploratoryPopulation2,949 adults with multiple sclerosis pooled from 25 studies (49 articles were eligible for review)InterventionNabiximols, a THC/CBD oromucosal spray already approved as add-on therapy for MS spasticityComparatorPlacebo or standard care across the pooled randomized and non-randomized studiesPrimary Outcomes AssessedBladder function, sleep disruption, spasm quality, and gait/timed walkSecondary OutcomeSubject Global Impression of Change (SGIC) at one monthDatabases SearchedWeb of Science, MEDLINE via PubMed, Cochrane CENTRAL, and Embase, searched September 10, 2025Main FindingSignificant improvement in spasm quality, bladder function, sleep disruption, and timed walk
Stopping Ozempic may lead to regaining the weight youve lost and could result in elevated blood sugar levels and increased insulin resistance
-25% BIOTECH USA Beef Protein 58.50 / 114.42
Novo immediately threatened to sue, and then the FDA said that it plans to take decisive steps to limit access to the active ingredients in popular GLP-1 drugs like Wegovy, Ozempic and Zepbound